Mallinckrodt Presents Latest Health Economics Data on Acthar Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Source :: PR Newswire. October 26, 2023
Publication Year :: 2023
Abstract: -- Findings from two health economics analyses of Acthar Gel provide further insight into its cost-effectiveness as a treatment option for advanced symptomatic sarcoidosis,[sup.1] and its impact on clinical, economic, [...]

Subjects :: United States. Food and Drug Administration
Mallinckrodt PLC
Health care industry -- Economic aspects
Managed care plans (Medical care) -- Economic aspects
Drug approval -- Economic aspects
Pharmacy -- Economic aspects
ACTH -- Economic aspects
Pharmaceutical industry -- Economic aspects
Health care industry
Business
News, opinion and commentary

Tools